Oral Microbiome and Cognitive Decline

This is a curated page. Report corrections to Microbewiki.

Introduction

(Figure 1) Graphical abstract that represents the variety of diseases and conditions that our oral microbiome may be connected to. [https://doi.org/10.3390/microorganisms8020308

By Evan Dean

At right is a sample image insertion. It works for any image uploaded anywhere to MicrobeWiki.

The insertion code consists of:
Double brackets: [[
Filename: PHIL_1181_lores.jpg
Thumbnail status: |thumb|
Pixel size: |300px|
Placement on page: |right|
Legend/credit: Electron micrograph of the Ebola Zaire virus. This was the first photo ever taken of the virus, on 10/13/1976. By Dr. F.A. Murphy, now at U.C. Davis, then at the CDC. Every image requires a link to the source.
Closed double brackets: ]]

Other examples:
Bold
Italic
Subscript: H₂O
Superscript: Fe³⁺

Evaluation rubric
The page should have minimum 3,000 words and three figures. Number each figure and call out in text, as for example (Figure 1). Some primary research must be cited. Evaluation is based on: writing fluency, including grammar and proofreading; specific details and creative thought; and scientific understanding of microbes.

Sample citations:
A citation code consists of a hyperlinked reference within "ref" begin and end codes.
To repeat the citation for other statements, the reference needs to have a names: "<ref name=aa>"
The repeated citation works like this, with a forward slash.

Alzheimer's Disease Overview

Alzheimer's disease (AD) is the most common form of dementia, affecting millions of people worldwide and posing significant public health challenges (Ballard et al. 2011). It is a progressive neurodegenerative disorder characterized by cognitive decline, memory loss, and impaired daily functioning (Scheltens et al. 2016). The exact cause of AD remains unclear, but it is believed to involve a complex interplay of genetic, environmental, and lifestyle factors (Querfurth and LaFerla 2010). At the cellular level, two hallmark features of AD are the presence of extracellular amyloid plaques and intracellular neurofibrillary tangles (Scheltens et al. 2016). Amyloid plaques are primarily composed of aggregated amyloid-β (Aβ) peptides, which result from the cleavage of amyloid precursor protein (APP) by β- and γ-secretases (Querfurth and LaFerla 2010). The accumulation of Aβ peptides is thought to play a critical role in the pathogenesis of AD, although the exact mechanisms by which they contribute to neurodegeneration remain under investigation (Ballard et al. 2011). Increasing evidence suggests that bacteria may play a role in the development of AD. One hypothesis is that certain bacterial infections, particularly those involving the oral cavity, can induce systemic inflammation and the production of pro-inflammatory cytokines, which may contribute to neuroinflammation and the accumulation of amyloid plaques (Querfurth and LaFerla 2010). In fact, some studies have identified specific oral pathogens, such as Porphyromonas gingivalis, in the brains of AD patients, supporting the potential link between oral microbiome dysbiosis and AD (Scheltens et al. 2016). Given the significant public health burden of AD, understanding the potential role of bacteria and other factors in its pathogenesis is critical for developing effective prevention and treatment strategies (Ballard et al. 2011). Further research is needed to elucidate the complex interplay between the oral microbiome, systemic inflammation, and neurodegenerative processes in AD and other cognitive disorders.

Alzheimers Disease Overview

Include some current research, with at least one figure showing data.

Section 3

Include some current research, with at least one figure showing data.

References

Authored for BIOL 238 Microbiology, taught by Joan Slonczewski, 2023, Kenyon College